{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:18:09Z","timestamp":1790702289057,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The rupture of the corpus luteum (CL) may occur at all stages of a woman\u2019s reproductive life. Bleeding of the ruptured CL varies from self-limiting hemorrhage to massive hemoperitoneum, causing the shock and subsequent emergency surgery. But hemoperitoneum secondary to ruptured CL is a rare complication and situation for women with bleeding disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We here describe a case of severe CL hemorrhage with factor VIII deficiency. We chose conservative management instead of surgery for the abnormal hemostatic condition. With blood product and factor concentrate support, conservative management was successful in avoiding surgery in the episode of bleeding.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Gynecologist should be alert for the patients with abnormal hemostatic condition. Selective patients presenting with CL hemoperitoneum association with bleeding disorders may undergo conservative management and avoid the risk of surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-022-02000-9","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T07:03:03Z","timestamp":1665471783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Corpus luteum hemorrhage with acquired hemophilia A: a case report and literature review"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-6010","authenticated-orcid":false,"given":"Xiaofei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0099-7678","authenticated-orcid":false,"given":"Shaoru","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"2000_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4274\/tjod.galenos.2020.40359","volume":"17","author":"MV Medvediev","year":"2020","unstructured":"Medvediev MV, Malvasi A, Gustapane S, Tinelli A. Hemorrhagic corpus luteum: clinical management update. J Turk Soc Obstet Gynecol. 2020;17:300\u20139.","journal-title":"J Turk Soc Obstet Gynecol"},{"key":"2000_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2516.2006.01399.x","volume":"13","author":"JH Payne","year":"2007","unstructured":"Payne JH, Maclean RM, Hampton KK, Baxter AJ, Makris M. Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill. Haemophilia. 2007;13:93\u20137.","journal-title":"Haemophilia"},{"key":"2000_CR3","first-page":"618","volume":"69","author":"T Motta","year":"2017","unstructured":"Motta T, Lagan\u00e0 AS, Valenti G, la Rosa VL, Noventa M, Vitagliano A, et al. Differential diagnosis and management of abnormal uterine bleeding in adolescence. Minerva Ginecol. 2017;69:618\u201330.","journal-title":"Minerva Ginecol"},{"key":"2000_CR4","first-page":"537","volume":"39","author":"M Terzic","year":"2012","unstructured":"Terzic M, Likic I, Pilic I, Bila J, Knezevic N. Conservative management of massive hematoperitoneum caused by ovulation in a patient with severe form of von Willebrand disease\u2014a case report. Clin Exp Obstet Gynecol. 2012;39:537\u201340.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"5 Pt 2","key":"2000_CR5","first-page":"887","volume":"99","author":"RR Jarvis","year":"2002","unstructured":"Jarvis RR, Olsen ME. Type I von Willebrand\u2019s disease presenting as recurrent corpus hemorrhagicum. Obstet Gynecol. 2002;99(5 Pt 2):887\u20138.","journal-title":"Obstet Gynecol"},{"key":"2000_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1471-0528.1991.tb13514.x","volume":"98","author":"IA Greer","year":"1991","unstructured":"Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol. 1991;98:909\u201318.","journal-title":"Br J Obstet Gynaecol"},{"key":"2000_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1046\/j.1365-2516.1998.00143.x","volume":"4","author":"A Gomez","year":"1998","unstructured":"Gomez A, Lucia JF, Perella M, Aguilar C. Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand\u2019s disease. Haemophilia. 1998;4:60\u20132.","journal-title":"Haemophilia"},{"key":"2000_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1046\/j.1365-2516.1998.01772.x","volume":"4","author":"K Ghosh","year":"1998","unstructured":"Ghosh K, Mohanty D, Pathare AV, Jijina F. Recurrent haemoperitoneum in a female patient with type III von Willebrand\u2019s disease responded to administration of oral contraceptive. Haemophilia. 1998;4:767\u20138.","journal-title":"Haemophilia"},{"key":"2000_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00001721-200104000-00007","volume":"12","author":"SS Meschengieser","year":"2001","unstructured":"Meschengieser SS, Alberto MF, Salvi\u00fa J, Bermejo E, Lazzari MA. Recurrent haemoperitoneum in a mild von Willebrand\u2019s disease combined with a storage pool deficit. Blood Coagul Fibrinolysis. 2001;12:207\u20139.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2000_CR10","first-page":"431","volume":"76","author":"E Bottini","year":"1991","unstructured":"Bottini E, Pareti FI, Mari D, Mannucci PM, Muggiasca ML, Conti M. Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports. Haematologica. 1991;76:431\u20133.","journal-title":"Haematologica"},{"key":"2000_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/PL00008423","volume":"160","author":"A Koussi","year":"2001","unstructured":"Koussi A, Economou M, Athanasiou-Metaxa M. Intra-abdominal hemorrhage due to a ruptured corpus luteum cyst in a girl with congenital afibrinogenemia. Eur J Pediatr. 2001;160:196.","journal-title":"Eur J Pediatr"},{"key":"2000_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ajh.2830490427","volume":"49","author":"G Castaman","year":"1995","unstructured":"Castaman G, Ruggeri M, Rodeghiero F. Congenital afibrinogenemia: successful prevention of recurrent hemoperitoneum during ovulation by oral contraceptive. Am J Hematol. 1995;49:363\u20134.","journal-title":"Am J Hematol"},{"key":"2000_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1600-0412.2010.01034.x","volume":"90","author":"SE Cetinkaya","year":"2011","unstructured":"Cetinkaya SE, Pabuccu EG, Ozmen B, Dokmeci F. Recurrent massive hemoperitoneum due to ovulation as a clinical sign in congenital afibrinogenemia. Acta Obstet Gynecol Scand. 2011;90:192\u20134.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2000_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3109\/00016348109154141","volume":"60","author":"D Schneider","year":"1981","unstructured":"Schneider D, Bukovsky I, Kaufman S, Sadovsky G, Caspi E. Severe ovarian hemorrhage in congenital afibrinogenemia. Acta Obstet Gynecol Scand. 1981;60:431.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2000_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00043426-199605000-00031","volume":"18","author":"PM O\u2019Brien","year":"1996","unstructured":"O\u2019Brien PM, DiMichele DM, Walterhouse DO. Management of an acute hemorrhagic ovarian cyst in a female patient with hemophilia A. J Pediatr Hematol Oncol. 1996;18:233\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2000_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/ard.60.5.527","volume":"60","author":"G Castellino","year":"2001","unstructured":"Castellino G, Cuadrado MJ, Godfrey T, Khamashta MA, Hughes GR. Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment. Ann Rheum Dis. 2001;60:527\u201330.","journal-title":"Ann Rheum Dis"},{"key":"2000_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/0961203310383300","volume":"20","author":"LYS Yamakami","year":"2011","unstructured":"Yamakami LYS, de Araujo DB, Silva CA, Baracat EC, de Carvalho JF. Severe hemorrhagic corpus luteum complicating anticoagulation in antiphospholipid syndrome. Lupus. 2011;20:523\u20136.","journal-title":"Lupus"},{"key":"2000_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJM199504133321504","volume":"332","author":"MA Khamashta","year":"1995","unstructured":"Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332:993\u20137.","journal-title":"N Engl J Med"},{"key":"2000_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000070186","volume":"55","author":"K Dafopoulos","year":"2003","unstructured":"Dafopoulos K, Galazios G, Georgadakis G, Boulbou M, Koutsoyiannis D, Plakopoulos A, et al. Two episodes of hemoperitoneum from luteal cysts rupture in a patient with congenital factor X deficiency. Gynecol Obstet Invest. 2003;55:114\u20135.","journal-title":"Gynecol Obstet Invest"},{"key":"2000_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2516.2008.01680.x","volume":"14","author":"N Singh","year":"2008","unstructured":"Singh N, Neeta S, Gupta N, Nupur G, Sarangi S, Shikha S, et al. Corpus luteal hemorrhage: an unusual manifestation of congenital factor XIII deficiency. Haemophilia. 2008;14:667\u20138.","journal-title":"Haemophilia"},{"key":"2000_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/MBC.0000000000000303","volume":"26","author":"RK Badyal","year":"2015","unstructured":"Badyal RK, Jain K, Mandrelle K, John MJ, Kakkar N, Bose SK, et al. Recurrent hemoperitoneum secondary to haemorrhage from the corpus luteum unmasks factor V deficiency. Blood Coagul Fibrinolysis. 2015;26:703\u20136.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2000_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/01443610801967174","volume":"28","author":"R Faraj","year":"2008","unstructured":"Faraj R, Martindale E, Hill S. Massive ovarian cyst haemorrhage with haemoperitoneum as a complication of long-term anticoagulation. J Obstet Gynaecol. 2008;28:250\u20131.","journal-title":"J Obstet Gynaecol"},{"key":"2000_CR23","first-page":"1","volume":"238","author":"J von Silwer","year":"1973","unstructured":"von Silwer J. Willebrand\u2019s disease in Sweden. Acta Paediatr Scand Suppl. 1973;238:1\u2013159.","journal-title":"Acta Paediatr Scand Suppl"},{"key":"2000_CR24","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1046\/j.1538-7836.2003.00338.x","volume":"1","author":"M Lak","year":"2003","unstructured":"Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci PM. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost. 2003;1:1852\u20133.","journal-title":"J Thromb Haemost"},{"key":"2000_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.thromres.2019.09.006","volume":"196","author":"M Menegatti","year":"2020","unstructured":"Menegatti M, Palla R. Clinical and laboratory diagnosis of rare coagulation disorders (RCDs). Thromb Res. 2020;196:603\u20138.","journal-title":"Thromb Res"},{"key":"2000_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/jog.12228","volume":"40","author":"L Chen","year":"2014","unstructured":"Chen L, Ding J, Hua K. Comparative analysis of laparoscopy versus laparotomy in the management of ovarian cyst during pregnancy. J Obstet Gynaecol Res. 2014;40:763\u20139.","journal-title":"J Obstet Gynaecol Res"},{"key":"2000_CR27","first-page":"533","volume":"67","author":"J Itskovitz","year":"1982","unstructured":"Itskovitz J, Brandes JM, Urbach J, Fisher M. Ovarian hematoma and hemoperitoneum complicating anticoagulant therapy. Int Surg. 1982;67:533\u20134.","journal-title":"Int Surg"},{"key":"2000_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00404-014-3394-2","volume":"291","author":"A Gupta","year":"2015","unstructured":"Gupta A, Gupta S, Manaktala U, Gupta MM, Solanki V. Conservative management of corpus luteum haemorrhage in patients on anticoagulation: a report of three cases and review of literature. Arch Gynecol Obstet. 2015;291:427\u201331.","journal-title":"Arch Gynecol Obstet"},{"issue":"suppl","key":"2000_CR29","first-page":"1","volume":"138","author":"I Elezovic","year":"2010","unstructured":"Elezovic I. Acquired haemophilia syndrome: pathophysiology and therapy. Srp Arh Celok Lek. 2010;138(suppl):1.","journal-title":"Srp Arh Celok Lek"},{"key":"2000_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/10245332.2017.1319115","volume":"22","author":"M Franchini","year":"2017","unstructured":"Franchini M, Vaglio S, Marano G, Mengoli C, Gentili S, Pupella S, et al. Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology. 2017;22:514\u201320.","journal-title":"Hematology"},{"key":"2000_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.transci.2018.10.011","volume":"57","author":"J Charlebois","year":"2018","unstructured":"Charlebois J, Rivard G\u00c9, St-Louis J. Management of acquired hemophilia A: review of current evidence. Transfus Apheres Sci. 2018;57:717\u201320.","journal-title":"Transfus Apheres Sci"},{"key":"2000_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ajh.24777","volume":"92","author":"R Kruse-Jarres","year":"2017","unstructured":"Kruse-Jarres R, Kempton CL, Baudo F, Collins PW, Knoebl P, Leissinger CA, et al. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol. 2017;92:695\u2013705.","journal-title":"Am J Hematol"},{"key":"2000_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.12891\/ceog1899.2015","volume":"42","author":"AS Lagan\u00e0","year":"2015","unstructured":"Lagan\u00e0 AS, Sofo V, Salmeri FM, Chiofalo B, Ciancimino L, Triolo O. Post-partum management in a patient affected by thrombotic thrombocytopenic purpura: case report and review of literature. Clin Exp Obstet Gynecol. 2015;42:90\u20134.","journal-title":"Clin Exp Obstet Gynecol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-02000-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T19:03:29Z","timestamp":1665515009000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-02000-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-02000-9","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"12 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient provided informed consent, which was registered in the medical record. We obtained the written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A copy of this consent to publish is available for review by the editor of the journal. Written consent for publication was obtained from the patient in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"418"}}